TY  -  
T1  - Pasireotide administration after pancreaticoduodenectomy may decrease clinically relevant postoperative pancreatic fistula in high-risk patients with small pancreatic ducts, soft pancreatic parenchyma and cystic or neuroendocrine neoplasia 
SN  -  /  
UR  - http://hdl.handle.net/10138/328205 
T3  -  
A1  - Vuorela, Tiina; Mustonen, Harri; Arto, Kokkola; Caj, Haglund; Hanna, Seppänen 
A2  -  
PB  -  
Y1  - 2020 
LA  - eng 
AB  - Objectives Post-operative pancreatic fistula (POPF) is a feared complication after a pancreaticoduodenectomy. Previously in a randomized trial found fewer clinically relevant fistulas (CR-POPF) accompanying administration of perioperative pasireotide. Our hospital previously found that the risk for CR-POPF reached 7% in pancreaticoduodenectomy patients. Here, we aimed to determine the CR-POPF rate accompanying prophylactic pasireotide in patients with a normal pancreas at resection level. Method... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - 3126 Surgery, anesthesiology, intensive care, radiology; pancreatic surgery; pancreatic fistula; post-operative complications; SURGERY; Post-operative complications; Pancreatic surgery; Pancreatic fistula; INTERNATIONAL STUDY-GROUP; PREDICTION 
N1  -   
PP  -  
ER  -